Search by Drug Name or NDC

    NDC 75826-0118-10 Phenohytro .0194; .1037; 16.2; .0065 mg/1; mg/1; mg/1; mg/1 Details

    Phenohytro .0194; .1037; 16.2; .0065 mg/1; mg/1; mg/1; mg/1

    Phenohytro is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Winder Laboratories, LLC. The primary component is ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE.

    Product Information

    NDC 75826-0118
    Product ID 75826-118_9af244ce-8841-4443-e053-2995a90af4e3
    Associated GPIs 49109904050320
    GCN Sequence Number 004777
    GCN Sequence Number Description phenobarb/hyoscy/atropine/scop TABLET 16.2 MG ORAL
    HIC3 J2A
    HIC3 Description BELLADONNA ALKALOIDS
    GCN 74070
    HICL Sequence Number 035019
    HICL Sequence Number Description PHENOBARBITAL/HYOSCYAMINE SULF/ATROPINE SULF/SCOPOLAMINE HB
    Brand/Generic Generic
    Proprietary Name Phenohytro
    Proprietary Name Suffix n/a
    Non-Proprietary Name PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength .0194; .1037; 16.2; .0065
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE
    Labeler Name Winder Laboratories, LLC
    Pharmaceutical Class Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule CIV
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 75826-0118-10 (75826011810)

    NDC Package Code 75826-118-10
    Billing NDC 75826011810
    Package 100 TABLET in 1 BOTTLE, PLASTIC (75826-118-10)
    Marketing Start Date 2016-02-29
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 27c8baac-f8ce-46d8-8a0f-ff769dd408d9 Details

    Revised: 12/2019